Sponsored by
Small-Cap Investing
  •  

Cognos Watches Its Contracts Grow

By Tom Taulli April 5, 2005 Comments (0)

0 Recommendations

A justification for M&A in the software industry is that it has become exceedingly difficult to land megaclients. After all, information technology budgets are tight. And, over the past 20 years, companies have already invested a significant amount in IT. With the large number of software vendors, customers also realize they can negotiate heavily on pricing.

But, as for Cognos (Nasdaq: COGN), the company reported significant customer wins in its fourth-quarter report. In fact, the company landed its first contract above $10 million.

Moreover, Cognos added 1,215 contracts in excess of $50,000, 208 in excess of $200,000, and 18 in excess of $1 million. Some of the new customers include Abbott Laboratories (NYSE: ABT), Amazon.com (Nasdaq: AMZN), CDW (Nasdaq: CDWC), CircuitCity (NYSE: CC), and even the U.S. Marines.

In the fourth quarter, revenues surged 27% to $256.3 million, and profits increased 18% to $54.3 million. For the full year, revenues increased 21% to $825.5 million, and net income increased 35% to $136.6 million.

Cognos is a leader in business intelligence reporting. The significance of its service is quite simple: Companies spend millions in developing information technology systems yet have limited ability to analyze the data these systems provide. With Cognos, a company can mine and analyze myriad data sources, such as customer relationship management and enterprise resource planning systems -- within which vast amounts of proprietary customer and company data are contained. A company can find weaknesses in an organization and make forecasts, budgets, and model scenarios.

Essentially, companies need to understand the "why" behind their performance -- Cognos products are intended to offer a solution such that companies are able to discern root cause elements to under- and/or overperformance. The alternative is often unwieldy at best -- companies often gather it via Excel sheets, which are often difficult to manage on a real-time basis and lack the ability to distill data into granular bits.

But more and more, companies are looking to third-party providers like Cognos. And, according to the company's guidance, it looks like this trend will continue. In the next quarter, Cognos expects revenues between $202 million to $210 million with earnings per share ranging from $0.22 to $0.25. And full-year is expected to range from $930 million to $950 million with earnings per share between $1.55 and $1.62.

Why are customers willing to spend big money on Cognos software? Well, it is often difficult to determine the return on investment for software investments. However, with Cognos, companies are seeing a clear ROI -- which they will certainly pay for. True, digital companies such as Amazon.com generate huge amounts of data; but traditional companies, such as Circuit City and Abbott Laboratories, do so as well. If spending money on Cognos' solutions means mining more profits from customers and discerning just where opportunities lie, it is definitely a "must have" technology solution.

Fool contributor Tom Taulli does not own shares mentioned in this article.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 490809, ~/articles/articlehandler.aspx, 7/9/2008 5:06:30 AM, No ticker

FREE 1-Step Fool.com Access!

Already registered? Login Here

No, thanks

Simply enter your email address below to get:

  • Instant access to this article and all in-depth Motley Fool news and analysis.
  • A FREE FoolWatch Weekly email subscription — save time by getting the very best Motley Fool features and market coverage handpicked by Fool.com editors and delivered to you each week.

Related Tickers

Abbott Laboratories

ABT Up! $57.37 +3.18 (+5.87%) 4:00 PM
CAPS Rating:
749 Outperforms
60 Underperforms
Rate This Stock

Major Indices

S&P 5001,267.34+1.20%
DJIA11,384.21+1.36%
RSL 2K674.34+2.44%
NASD2,276.34+1.47%
Updated: 4:04:12 PM
Sponsored by:

The Motley Poll

Will the U.S. economy fall into recession?

Sponsored by: